High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study

BACKGROUND: 2018 American Heart Association/American College of Cardiology cholesterol guideline recommends statin in patients with chronic and/or stable liver disease for secondary prevention of atherosclerotic cardiovascular disease yet remains equivocal on the adequate intensity of statin for pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bea, Sungho, Oh, In‐Sun, Kim, Ju Hwan, Sinn, Dong Hyun, Chang, Yoosoo, Ryu, Seungho, Shin, Ju‐Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227280/
https://www.ncbi.nlm.nih.gov/pubmed/37066797
http://dx.doi.org/10.1161/JAHA.122.028310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227280/
https://www.ncbi.nlm.nih.gov/pubmed/37066797
http://dx.doi.org/10.1161/JAHA.122.028310

Ejemplares similares